Return to content in this issue

 

JAK Inhibition as a Therapeutic Strategy for IgG4-RD

Khan S1, Gordins P1, Durairaj S2

1Department of Immunology & Allergy, Castle Hill Hospital, Cottingham, UK
2Department of Haemato-Oncology, Castle Hill Hospital, Cottingham, UK

J Investig Allergol Clin Immunol 2021; Vol 31(3) : 280-281
doi: 10.18176/jiaci.0654

Key words: IgG4-related disease, IgG4-RD, Fibrosis, Cytokines, JAK inhibition